Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

1-25 of 64 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3

Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: Pathogenesis, risk of infection, and disease management.
Alvarez E, Longbrake EE, Rammohan KW, Stankiewicz J, Hersh CM
Mult Scler Relat Disord, 79:105009, 15 Sep 2023
Cited by: 4 articles | PMID: 37783194
Add to export list Review
Bruton's Tyrosine Kinase Inhibitors: The Next Frontier of B-Cell-Targeted Therapies for Cancer, Autoimmune Disorders, and Multiple Sclerosis.
Garg N, Padron EJ, Rammohan KW, Goodman CF
J Clin Med, 11(20):6139, 18 Oct 2022
Cited by: 12 articles | PMID: 36294458 | PMCID: PMC9604914
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The North American Registry for Care and Research in Multiple Sclerosis (NARCRMS).
Rammohan KW, Halper J, Lang S, Murphy SM, Patton L, Goodman C, Li DKB
Int J MS Care, 23(6):269-275, 01 Nov 2021
Cited by: 1 article | PMID: 35035298 | PMCID: PMC8745232
Add to export list Free full text in Europe PMC
COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COViMS Registry.
Newsome SD, Cross AH, Fox RJ, Halper J, Kanellis P, Bebo B, Li D, Cutter GR, Rammohan KW, Salter A
Neurol Neuroimmunol Neuroinflamm, 8(5):e1057, 24 Aug 2021
Cited by: 12 articles | PMID: 34429342 | PMCID: PMC8407145
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Peripheral nervous system electrodiagnostic abnormalities in predominantly Hispanic Multiple Sclerosis patients.
Lizarraga AA, Rammohan KW, Weinstock-Guttman B, Sharma K
Mult Scler Relat Disord, 56:103254, 04 Sep 2021
Cited by: 1 article | PMID: 34543858
Add to export list
Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis.
Shin RK, Rammohan KW, Williams MJ
Neurol Ther, 10(2):415-425, 04 Aug 2021
Cited by: 4 articles | PMID: 34347280 | PMCID: PMC8336531
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Longitudinal Study of Retinal Structure, Vascular, and Neuronal Function in Patients With Relapsing-Remitting Multiple Sclerosis: 1-Year Follow-Up.
Chen Q, Jiang H, Delgado S, Hernandez J, Alba DE, Gregori G, Rammohan KW, Porciatti V, Wang J
Transl Vis Sci Technol, 10(6):6, 01 May 2021
Cited by: 4 articles | PMID: 34111252 | PMCID: PMC8107487
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study.
Giovannoni G, Soelberg Sorensen P, Cook S, Rammohan KW, Rieckmann P, Comi G, Dangond F, Hicking C, Vermersch P
Mult Scler, 25(6):819-827, 02 May 2018
Cited by: 25 articles | PMID: 29716436 | PMCID: PMC6460686
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, [...] OPERA I and OPERA II Clinical Investigators
N Engl J Med, 376(3):221-234, 21 Dec 2016
Cited by: 776 articles | PMID: 28002679
Add to export list
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA, CARE-MS II Investigators
Neurology, 87(19):1985-1992, 12 Oct 2016
Cited by: 34 articles | PMID: 27733571 | PMCID: PMC5109953
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, [...] ORATORIO Clinical Investigators
N Engl J Med, 376(3):209-220, 21 Dec 2016
Cited by: 769 articles | PMID: 28002688
Add to export list
Fingolimod: a review of its mode of action in the context of its efficacy and safety profile in relapsing forms of multiple sclerosis.
Jeffery DR, Rammohan KW, Hawker K, Fox E
Expert Rev Neurother, 16(1):31-44, 13 Jan 2016
Cited by: 12 articles | PMID: 26587577
Add to export list Review
Impaired retinal microcirculation in multiple sclerosis.
Jiang H, Delgado S, Tan J, Liu C, Rammohan KW, DeBuc DC, Lam BL, Feuer WJ, Wang J
Mult Scler, 22(14):1812-1820, 22 Feb 2016
Cited by: 30 articles | PMID: 26903007 | PMCID: PMC4993688
Add to export list Free full text in Europe PMC
Clinical Expression of Multiple Sclerosis in Hispanic Whites of Primarily Caribbean Ancestry.
Hadjixenofontos A, Beecham AH, Manrique CP, Pericak-Vance MA, Tornes L, Ortega M, Rammohan KW, McCauley JL, Delgado SR
Neuroepidemiology, 44(4):262-268, 11 Jul 2015
Cited by: 15 articles | PMID: 26184860
Add to export list
In Vivo Characterization of Retinal Microvascular Network in Multiple Sclerosis.
Jiang H, Delgado S, Liu C, Rammohan KW, DeBuc DC, Lam BL, Wang J
Ophthalmology, 123(2):437-438, 20 Aug 2015
Cited by: 18 articles | PMID: 26299696 | PMCID: PMC4724448
Add to export list Free full text in Europe PMC
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.
Goodman AD, Bethoux F, Brown TR, Schapiro RT, Cohen R, Marinucci LN, Henney HR, Blight AR, MS-F203, MS-F204, and Extension Study Investigators
Mult Scler, 21(10):1322-1331, 12 Jan 2015
Cited by: 24 articles | PMID: 25583832 | PMCID: PMC4561451
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review.
Delgado SR, Maldonado J, Rammohan KW
J Neurovirol, 20(5):531-537, 01 Jul 2014
Cited by: 13 articles | PMID: 24981832
Add to export list Review
Dimethyl fumarate for treating relapsing multiple sclerosis.
Sheremata W, Brown AD, Rammohan KW
Expert Opin Drug Saf, 14(1):161-170, 08 Nov 2014
Cited by: 23 articles | PMID: 25382392
Add to export list Review
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Calabresi PA, Radue EW, Goodin D, Jeffery D, Rammohan KW, Reder AT, Vollmer T, Agius MA, Kappos L, Stites T, Li B, Cappiello L, von Rosenstiel P, Lublin FD
Lancet Neurol, 13(6):545-556, 28 Mar 2014
Cited by: 451 articles | PMID: 24685276
Add to export list
Fulminant myelitis with NMO IgG antibody following treatment with interferon alpha.
Usmani N, McCarthy M, Rammohan KW, Ortega MR
J Neurol, 261(1):240-241, 12 Dec 2013
Cited by: 6 articles | PMID: 24337354
Add to export list
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA, CARE-MS II investigators
Lancet, 380(9856):1829-1839, 01 Nov 2012
Cited by: 604 articles | PMID: 23122650
Add to export list
Vitamin B12 deficiency mimicking NMO spectrum disorder.
Tornes L, Ortega MR, Delgado S, Rammohan KW
Mult Scler, 18(11):1659-1660, 03 Jul 2012
Cited by: 2 articles | PMID: 22760101
Add to export list
CLIPPERS complicating multiple sclerosis causing concerns of CNS lymphoma.
Ortega MR, Usmani N, Parra-Herran C, Adams DJ, Steingo B, Rammohan KW
Neurology, 79(7):715-716, 01 Aug 2012
Cited by: 16 articles | PMID: 22855867
Add to export list
NMO spectrum presenting as partial myelitis.
Ortega MR, Tornes L, Rammohan KW
Mult Scler, 19(2):252-253, 19 Apr 2012
Cited by: 2 articles | PMID: 22516795
Add to export list
Focal segmental glomerulosclerosis secondary to subcutaneous interferon β-1a treatment in a patient with multiple sclerosis.
Tornes L, Delgado S, Garcia-Buitrago M, Ortega MR, Rammohan KW
Mult Scler Relat Disord, 1(3):148-151, 14 Mar 2012
Cited by: 3 articles | PMID: 25877082
Add to export list

1-25 of 64 results

1 2 3

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

Partnerships & funding